Patterson Matthew R 4
4 · Homology Medicines, Inc. · Filed Jun 22, 2021
Insider Transaction Report
Form 4
Patterson Matthew R
Director
Transactions
- Award
Option (Right to Buy)
2021-06-17+18,000→ 18,000 totalExercise: $7.26Exp: 2031-06-17→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.